ICOA
NGNE icon

Investment Centers of America’s Neurogene NGNE Stock Holding History

Investment Centers of America’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-617
Closed -$175K – 320
2017
Q3 		$175K Buy
+617
New +$177K 0.01% 558
2017
Q2 		– Sell
-518
Closed -$172K – 633
2017
Q1 		$172K Buy
+518
New +$182K 0.01% 591

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Investment Centers of America's NGNE Position: Q4 2017 in Review

Investment Centers of America sold out of Neurogene (NGNE) in Q4 2017, closing a stake of 617 shares — an estimated $175K sold.

Investment Centers of America first reported a position in NGNE in Q1 2017 and held it in 2 quarters. The position peaked at $175K in Q3 2017. 52 funds tracked by Wall St. Rank hold NGNE as of Q4 2017.

  • Investment Centers of America reported no remaining Neurogene position as of Q4 2017 after selling out during the quarter.
  • Investment Centers of America sold 617 Neurogene shares in Q4 2017, an estimated $175K.
  • Investment Centers of America first reported a position in Neurogene in Q1 2017 and held it in 2 quarters.
  • Investment Centers of America's Neurogene position peaked at $175K in Q3 2017.
  • 52 funds tracked by Wall St. Rank held Neurogene as of Q4 2017.

Based on Investment Centers of America's 13F filing for Q4 2017, filed 14 Feb 2018.